Daiichi Sankyo (OTCMKTS:DSNKY) Reaches New 12-Month Low – What’s Next?

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as $22.47 and last traded at $22.66, with a volume of 412148 shares. The stock had previously closed at $22.65.

Daiichi Sankyo Trading Up 0.0 %

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.77 and a quick ratio of 2.11. The firm has a market cap of $43.24 billion and a price-to-earnings ratio of 26.35. The business’s 50-day moving average price is $26.50 and its two-hundred day moving average price is $31.47.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.22 EPS for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. Equities analysts expect that Daiichi Sankyo Company, Limited will post 0.73 earnings per share for the current year.

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Recommended Stories

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.